MiR-124 targets Slug to regulate epithelial–mesenchymal transition and metastasis of breast cancer
Open Access
- 17 December 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 34 (3), 713-722
- https://doi.org/10.1093/carcin/bgs383
Abstract
MicroRNAs (miRNAs or miR) have been integrated into tumorigenic programs as either oncogenes or tumor suppressor genes. The miR-124 was reported to be attenuated in several tumors, such as glioma, medulloblastoma and hepatocellular carcinoma. However, its role in cancer remains greatly elusive. In this study, we show that the miR-124 expression is significantly suppressed in human breast cancer specimens, which is reversely correlated to histological grade of the cancer. More intriguingly, ectopic expression of miR-124 in aggressive breast cancer cell lines MDA-MB-231 and BT-549 strongly inhibits cell motility and invasive capacity, as well as the epithelial–mesenchymal transition process. Also, lentivirus-delivered miR-124 endows MDA-MB-231 cells with the ability to suppress cell colony formation in vitro and pulmonary metastasis in vivo . Further studies have identified the E-cadherin transcription repressor Slug as a direct target gene of miR-124; its downregulation by miR-124 increases the expression of E-cadherin, a hallmark of epithelial cells and a repressor of cell invasion and metastasis. Moreover, knockdown of Slug notably impairs the motility of MDA-MB-231 cells, whereas re-expression of Slug abrogates the reduction of motility and invasion ability induced by miR-124 in MDA-MB-231 cells. These findings highlight an important role for miR-124 in the regulation of invasive and metastatic potential of breast cancer and suggest a potential application of miR-124 in cancer treatment.Keywords
This publication has 37 references indexed in Scilit:
- microRNA involvement in human cancerCarcinogenesis: Integrative Cancer Research, 2012
- Function of the Zinc-Finger Transcription FactorSNAI2in Cancer and DevelopmentAnnual Review of Genetics, 2007
- Genetic Unmasking of an Epigenetically Silenced microRNA in Human Cancer CellsCancer Research, 2007
- Overview of Resistance to Systemic Therapy in Patients with Breast CancerAdvances in experimental medicine and biology, 2007
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- MicroRNAs as Oncogenes and Tumor SuppressorsNew England Journal of Medicine, 2005
- MicroRNA expression profiles classify human cancersNature, 2005
- MicroRNAs: Genomics, Biogenesis, Mechanism, and FunctionCell, 2004
- Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence.1995
- Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.1987